ABO Blood Group as a Model for Platelet Glycan Modification in Arterial Thrombosis. Issue 7 (July 2015)

• Record Type: Journal Article
• Authors: Zhong, Ming; Zhang, Hanrui; Reilly, John P.; Chrisitie, Jason D.; Ishihara, Mayumi; Kumagai, Tadahiro; Azadi, Parastoo; Reilly, Muredach P.
• Is Part Of: Arteriosclerosis, thrombosis, and vascular biology. Volume 35:Issue 7(2015)
• Publication Date: 2015-07
• Subjects: ABO blood-group systems -- acute coronary syndrome -- blood platelets -- glycoproteins -- thrombosis; Arteriosclerosis -- Periodicals; Thrombosis -- Periodicals; Blood-vessels -- Pathophysiology -- Periodicals; Electronic journals; 616.13
• DOI: 10.1161/ATVBAHA.115.305337
• Languages: English
• ISSNs: 1079-5642

Abstract

Abstract : ABO blood groups have long been associated with cardiovascular disease, thrombosis, and acute coronary syndromes. Many studies over the years have shown type O blood group to be associated with lower risk of cardiovascular disease than non–type O blood groups. However, the mechanisms underlying this association remain unclear. Although ABO blood group is associated with variations in concentrations of circulating von Willebrand Factor and other endothelial cell adhesion molecules, ABO antigens are also present on several platelet surface glycoproteins and glycosphingolipids. As we highlight in this platelet-centric review, these glycomic modifications may affect platelet function in arterial thrombosis. More broadly, improving our understanding of the role of platelet glycan modifications in acute coronary syndromes may inform future diagnostics and therapeutics for cardiovascular diseases.